INOVIO PHARMACEUTICALS INC
INONASDAQ🏆 #3936 by market capEarnings Aug 12US Equity
$0.76▼ $0.01 (−1.36%)
Live1h▲ 1.0%
24h▼ 1.4%
7d▲ 12.1%
14d▼ 27.7%
30d▼ 35.2%
1y▼ 48.6%
🏦Market Cap
$52M
Small Cap
📈Revenue Growth (YoY)
-70.0%
Declining
📊Gross Margin
0.0%
Thin
💵FCF Margin
0.0%
Thin
⚖️P/S Ratio
0.0x
Cheap
Otter Score
61
Fair
📊
Analyst Ratings
Price
$0.7554
Total
17
Raised
0
Lowered
5
Avg PT
$2.50
H / L
$3 / $3
| Institution | Action | Rating | Date |
|---|---|---|---|
Piper Sandler | Reiterated | Overweight | 2026-08-03 |
HC Wainwright & Co. | Reiterated | Neutral | 2026-06-01 |
Oppenheimer | Reiterated | Outperform | 2025-05-14 |
RBC Capital | Reiterated | Sector Perform | 2025-05-14 |
JMP Securities | Reiterated | Market Outperform | 2025-01-10 |
Maxim Group | Downgraded | Buy → Hold | 2022-11-08 |
B of A Securities | Downgraded | Neutral → Underperform | 2022-10-31 |
Jefferies | Reiterated | Hold | 2021-06-24 |
Roth Capital | Downgraded | Neutral → Sell | 2020-11-16 |
Cantor Fitzgerald | Downgraded | Overweight → Neutral | 2020-09-27 |
Stifel | Downgraded | Buy → Hold | 2020-06-25 |
Benchmark | Reiterated | Buy | 2020-05-21 |
PiperJaffray | Reiterated | Overweight | 2020-01-03 |
Aegis Capital | Reiterated | Buy | 2016-11-07 |
Brean Capital | Reiterated | Buy | 2016-03-13 |
H.C. Wainwright | Reiterated | Buy | 2015-03-12 |
Stifel Nicolaus | Reiterated | Buy | 2014-05-07 |
One row per institution, most recent rating